2024-06-212025-06-302025-06-30false15792489JLC THE LANE LIMITED2025-11-2590010falseiso4217:GBPxbrli:pure157924892024-06-20157924892025-06-30157924892024-06-212025-06-30157924892024-06-19157924892024-06-20157924892024-06-202024-06-2015792489bus:SmallEntities2024-06-212025-06-3015792489bus:AuditExempt-NoAccountantsReport2024-06-212025-06-3015792489bus:FullAccounts2024-06-212025-06-3015792489bus:PrivateLimitedCompanyLtd2024-06-212025-06-3015792489core:WithinOneYear2025-06-3015792489core:AfterOneYear2025-06-3015792489core:WithinOneYear2024-06-2015792489core:AfterOneYear2024-06-2015792489core:ShareCapital2025-06-3015792489core:SharePremium2025-06-3015792489core:RevaluationReserve2025-06-3015792489core:OtherReservesSubtotal2025-06-3015792489core:RetainedEarningsAccumulatedLosses2025-06-3015792489core:ShareCapital2024-06-2015792489core:SharePremium2024-06-2015792489core:RevaluationReserve2024-06-2015792489core:OtherReservesSubtotal2024-06-2015792489core:RetainedEarningsAccumulatedLosses2024-06-2015792489core:LandBuildings2025-06-3015792489core:PlantMachinery2025-06-3015792489core:Vehicles2025-06-3015792489core:FurnitureFittings2025-06-3015792489core:OfficeEquipment2025-06-3015792489core:NetGoodwill2025-06-3015792489core:IntangibleAssetsOtherThanGoodwill2025-06-3015792489core:ListedExchangeTraded2025-06-3015792489core:UnlistedNon-exchangeTraded2025-06-3015792489core:LandBuildings2024-06-2015792489core:PlantMachinery2024-06-2015792489core:Vehicles2024-06-2015792489core:FurnitureFittings2024-06-2015792489core:OfficeEquipment2024-06-2015792489core:NetGoodwill2024-06-2015792489core:IntangibleAssetsOtherThanGoodwill2024-06-2015792489core:ListedExchangeTraded2024-06-2015792489core:UnlistedNon-exchangeTraded2024-06-2015792489core:LandBuildings2024-06-212025-06-3015792489core:PlantMachinery2024-06-212025-06-3015792489core:Vehicles2024-06-212025-06-3015792489core:FurnitureFittings2024-06-212025-06-3015792489core:OfficeEquipment2024-06-212025-06-3015792489core:NetGoodwill2024-06-212025-06-3015792489core:IntangibleAssetsOtherThanGoodwill2024-06-212025-06-3015792489core:ListedExchangeTraded2024-06-212025-06-3015792489core:UnlistedNon-exchangeTraded2024-06-212025-06-3015792489core:MoreThanFiveYears2024-06-212025-06-3015792489core:Non-currentFinancialInstruments2025-06-3015792489core:Non-currentFinancialInstruments2024-06-2015792489dpl:CostSales2024-06-212025-06-3015792489dpl:DistributionCosts2024-06-212025-06-3015792489core:LandBuildings2024-06-212025-06-3015792489core:PlantMachinery2024-06-212025-06-3015792489core:Vehicles2024-06-212025-06-3015792489core:FurnitureFittings2024-06-212025-06-3015792489core:OfficeEquipment2024-06-212025-06-3015792489dpl:AdministrativeExpenses2024-06-212025-06-3015792489core:NetGoodwill2024-06-212025-06-3015792489core:IntangibleAssetsOtherThanGoodwill2024-06-212025-06-3015792489dpl:GroupUndertakings2024-06-212025-06-3015792489dpl:ParticipatingInterests2024-06-212025-06-3015792489dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-212025-06-3015792489core:ListedExchangeTraded2024-06-212025-06-3015792489dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-212025-06-3015792489core:UnlistedNon-exchangeTraded2024-06-212025-06-3015792489dpl:CostSales2024-06-202024-06-2015792489dpl:DistributionCosts2024-06-202024-06-2015792489core:LandBuildings2024-06-202024-06-2015792489core:PlantMachinery2024-06-202024-06-2015792489core:Vehicles2024-06-202024-06-2015792489core:FurnitureFittings2024-06-202024-06-2015792489core:OfficeEquipment2024-06-202024-06-2015792489dpl:AdministrativeExpenses2024-06-202024-06-2015792489core:NetGoodwill2024-06-202024-06-2015792489core:IntangibleAssetsOtherThanGoodwill2024-06-202024-06-2015792489dpl:GroupUndertakings2024-06-202024-06-2015792489dpl:ParticipatingInterests2024-06-202024-06-2015792489dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-202024-06-2015792489core:ListedExchangeTraded2024-06-202024-06-2015792489dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-202024-06-2015792489core:UnlistedNon-exchangeTraded2024-06-202024-06-2015792489core:NetGoodwill2025-06-3015792489core:IntangibleAssetsOtherThanGoodwill2025-06-3015792489core:LandBuildings2025-06-3015792489core:PlantMachinery2025-06-3015792489core:Vehicles2025-06-3015792489core:FurnitureFittings2025-06-3015792489core:OfficeEquipment2025-06-3015792489core:AfterOneYear2025-06-3015792489core:WithinOneYear2025-06-3015792489core:ListedExchangeTraded2025-06-3015792489core:UnlistedNon-exchangeTraded2025-06-3015792489core:ShareCapital2025-06-3015792489core:SharePremium2025-06-3015792489core:RevaluationReserve2025-06-3015792489core:OtherReservesSubtotal2025-06-3015792489core:RetainedEarningsAccumulatedLosses2025-06-3015792489core:NetGoodwill2024-06-2015792489core:IntangibleAssetsOtherThanGoodwill2024-06-2015792489core:LandBuildings2024-06-2015792489core:PlantMachinery2024-06-2015792489core:Vehicles2024-06-2015792489core:FurnitureFittings2024-06-2015792489core:OfficeEquipment2024-06-2015792489core:AfterOneYear2024-06-2015792489core:WithinOneYear2024-06-2015792489core:ListedExchangeTraded2024-06-2015792489core:UnlistedNon-exchangeTraded2024-06-2015792489core:ShareCapital2024-06-2015792489core:SharePremium2024-06-2015792489core:RevaluationReserve2024-06-2015792489core:OtherReservesSubtotal2024-06-2015792489core:RetainedEarningsAccumulatedLosses2024-06-2015792489core:NetGoodwill2024-06-1915792489core:IntangibleAssetsOtherThanGoodwill2024-06-1915792489core:LandBuildings2024-06-1915792489core:PlantMachinery2024-06-1915792489core:Vehicles2024-06-1915792489core:FurnitureFittings2024-06-1915792489core:OfficeEquipment2024-06-1915792489core:AfterOneYear2024-06-1915792489core:WithinOneYear2024-06-1915792489core:ListedExchangeTraded2024-06-1915792489core:UnlistedNon-exchangeTraded2024-06-1915792489core:ShareCapital2024-06-1915792489core:SharePremium2024-06-1915792489core:RevaluationReserve2024-06-1915792489core:OtherReservesSubtotal2024-06-1915792489core:RetainedEarningsAccumulatedLosses2024-06-1915792489core:AfterOneYear2024-06-212025-06-3015792489core:WithinOneYear2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:CostValuation2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-212025-06-3015792489core:Non-currentFinancialInstrumentscore:CostValuation2025-06-3015792489core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-06-3015792489core:Non-currentFinancialInstrumentscore:CostValuation2024-06-2015792489core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-2015792489core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-2015792489bus:Director12024-06-212025-06-30

JLC THE LANE LIMITED

Registered Number
15792489
(England and Wales)

Unaudited Financial Statements for the Period ended
30 June 2025

JLC THE LANE LIMITED
Company Information
for the period from 21 June 2024 to 30 June 2025

Director

LLOYD, James Raymond

Registered Address

S24 West Wing Somerset House
Strand
London
WC2R 1LA

Registered Number

15792489 (England and Wales)
JLC THE LANE LIMITED
Statement of Financial Position
30 June 2025

Notes

2025

£

£

Current assets
Debtors31,595,724
Cash at bank and on hand1,224,569
2,820,293
Prepayments and accrued income85
Creditors amounts falling due within one year4(2,820,377)
Net current assets (liabilities)1
Total assets less current liabilities1
Net assets1
Capital and reserves
Called up share capital1
Shareholders' funds1
The financial statements were approved and authorised for issue by the Director on 25 November 2025, and are signed on its behalf by:
LLOYD, James Raymond
Director
Registered Company No. 15792489
JLC THE LANE LIMITED
Notes to the Financial Statements
for the period ended 30 June 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The financial statements have not been prepared on a going concern basis. The company was established to produce and manage the theatrical productions The Tempest and Much Ado About Nothing, which concluded their runs during the period. Following the completion of the productions, the company will no longer have any trading activity and will cease operations. The directors have decided that the company will be wound up within 12 months of the balance sheet date. As a result, the financial statements have been prepared on a non-going concern basis, and adjustments have been made where necessary to reflect the estimated realisable values of assets and to provide for any additional liabilities arising during the wind-down period. Liabilities have been recognised to the extent where third party investors are entitled to a share of net assets. No adjustments have been made to reflect any potential future income or expenses that would have occurred if the company were to continue as a going concern. The directors believe that the company will have sufficient resources to meet its obligations as they fall due during the wind-down period.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of theatre tickets and is recognised with reference to the performance date once sales have matured.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees
Excluding Directors:

2025
Average number of employees during the year17
3.Debtors: amounts due within one year

2025

£
Trade debtors / trade receivables299,406
Other debtors1,296,318
Total1,595,724
4.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables60,467
Accrued liabilities and deferred income2,759,910
Total2,820,377
5.Share capital
The ordinary share capital of the company during the period was: Allotted called up and fully paid 1 Ordinary Share of £1